TALOTTA, FRANCESCO
TALOTTA, FRANCESCO
Istituto di genetica e biofisica "Adriano Buzzati Traverso"- IGB - Sede Napoli
FRA-1 as a Regulator of EMT and Metastasis in Breast Cancer
2023 Casalino, L; Talotta, F; Matino, I; Verde, P
The Fra-1/AP-1 Oncoprotein: From the "Undruggable" Transcription Factor to Therapeutic Targeting
2022 Casalino, L; Talotta, F; Cimmino, A; Verde, P
Immunogenicity of a new gorilla adenovirus vaccine candidate for COVID-19
2021 Capone, S.; Raggioli, A.; Gentile, M.; Battella, S.; Lahm, A.; Sommella, A.; Contino, A. M.; Urbanowicz, R. A.; Scala, R.; Barra, F.; Leuzzi, A.; Lilli, E.; Miselli, G.; Noto, A.; Ferraiuolo, M.; Talotta, F.; Tsoleridis, T.; Castilletti, C.; Matusali, G.; Colavita, F.; Lapa, D.; Meschi, S.; Capobianchi, M.; Soriani, M.; Folgori, A.; Ball, J. K.; Colloca, S.; Vitelli, A.
The nuclear oncoprotein Fra-1: a transcription factor knocking on therapeutic applications' door
2020 Talotta, Francesco; Casalino, Laura; Verde, Pasquale
miR-340 inhibits tumor cell proliferation and induces apoptosis by targeting multiple negative regulators of p27 in non-small cell lung cancer
2015 Fernandez, S; Risolino, M; Mandia, N; Talotta, F; Soini, Y; Incoronato, M; Condorelli, G; Banfi, S; Verde, P
Transcription factor PREP1 induces EMT and metastasis by controlling the TGF-β-SMAD3 pathway in non-small cell lung adenocarcinoma
2014 Risolino, M.; Mandia, N.; Iavarone, F.; Dardaei, L.; Longobardi, E.; Fernandez, S.; Talotta, F.; Bianchi, F.; Pisati, F.; Spaggiari, L.; Harter, P. N.; Mittelbronn, M.; Schulte, D.; Incoronato, M.; Di Fiore, P. P.; Blasi, F.; Verde, P.
Heterodimerization with Fra-1 cooperates with the ERK pathway to stabilize c-Jun in response to the RAS oncoprotein
2010 Talotta F.; Mega T.; Bossis G.; Casalino L.; Basbous J.; JarielEncontre I.; Piechaczyk M.; Verde P.
An autoregulatory loop mediated by miR-21 and PDCD4 controls the AP-1 activity in RAS transformation
2009 Talotta F.; Cimmino A.; Matarazzo M.R.; Casalino L.; De Vita G.; D'Esposito M.; Di Lauro R.; Verde P.
A direct link between expression of urokinase plasminogen activator receptor, growth rate and oncogenic transformation in mouse embryonic fibroblasts
2007 Mazzieri, R; Furlan, F; D'Alessio, S; Zonari, E; Talotta, F; Verde, P; Blasi, F
Fra-1 promotes growth and survival in RAS-transformed thyroid cells by controlling cyclin A transcription
2007 Casalino, L; Bakiri, L; Talotta, F; Weitzman, Jb; Fusco, A; Yaniv, M; Verde, P
Urokinase plasminogen activator receptor affects bone homeostasis by regulating osteoblast and osteoclast
2007 Furlan F.; Galbiati C.; Jorgensen N.R.; Jensen JE.; Mrak E.; Rubinacci A.; Talotta F.; Verde P.; Blasi F.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| FRA-1 as a Regulator of EMT and Metastasis in Breast Cancer | 1-gen-2023 | Casalino, L; Talotta, F; Matino, I; Verde, P | |
| The Fra-1/AP-1 Oncoprotein: From the "Undruggable" Transcription Factor to Therapeutic Targeting | 1-gen-2022 | Casalino, L; Talotta, F; Cimmino, A; Verde, P | |
| Immunogenicity of a new gorilla adenovirus vaccine candidate for COVID-19 | 1-gen-2021 | Capone, S.; Raggioli, A.; Gentile, M.; Battella, S.; Lahm, A.; Sommella, A.; Contino, A. M.; Urbanowicz, R. A.; Scala, R.; Barra, F.; Leuzzi, A.; Lilli, E.; Miselli, G.; Noto, A.; Ferraiuolo, M.; Talotta, F.; Tsoleridis, T.; Castilletti, C.; Matusali, G.; Colavita, F.; Lapa, D.; Meschi, S.; Capobianchi, M.; Soriani, M.; Folgori, A.; Ball, J. K.; Colloca, S.; Vitelli, A. | |
| The nuclear oncoprotein Fra-1: a transcription factor knocking on therapeutic applications' door | 1-gen-2020 | Talotta, Francesco; Casalino, Laura; Verde, Pasquale | |
| miR-340 inhibits tumor cell proliferation and induces apoptosis by targeting multiple negative regulators of p27 in non-small cell lung cancer | 1-gen-2015 | Fernandez, S; Risolino, M; Mandia, N; Talotta, F; Soini, Y; Incoronato, M; Condorelli, G; Banfi, S; Verde, P | |
| Transcription factor PREP1 induces EMT and metastasis by controlling the TGF-β-SMAD3 pathway in non-small cell lung adenocarcinoma | 1-gen-2014 | Risolino, M.; Mandia, N.; Iavarone, F.; Dardaei, L.; Longobardi, E.; Fernandez, S.; Talotta, F.; Bianchi, F.; Pisati, F.; Spaggiari, L.; Harter, P. N.; Mittelbronn, M.; Schulte, D.; Incoronato, M.; Di Fiore, P. P.; Blasi, F.; Verde, P. | |
| Heterodimerization with Fra-1 cooperates with the ERK pathway to stabilize c-Jun in response to the RAS oncoprotein | 1-gen-2010 | Talotta F.; Mega T.; Bossis G.; Casalino L.; Basbous J.; JarielEncontre I.; Piechaczyk M.; Verde P. | |
| An autoregulatory loop mediated by miR-21 and PDCD4 controls the AP-1 activity in RAS transformation | 1-gen-2009 | Talotta F.; Cimmino A.; Matarazzo M.R.; Casalino L.; De Vita G.; D'Esposito M.; Di Lauro R.; Verde P. | |
| A direct link between expression of urokinase plasminogen activator receptor, growth rate and oncogenic transformation in mouse embryonic fibroblasts | 1-gen-2007 | Mazzieri, R; Furlan, F; D'Alessio, S; Zonari, E; Talotta, F; Verde, P; Blasi, F | |
| Fra-1 promotes growth and survival in RAS-transformed thyroid cells by controlling cyclin A transcription | 1-gen-2007 | Casalino, L; Bakiri, L; Talotta, F; Weitzman, Jb; Fusco, A; Yaniv, M; Verde, P | |
| Urokinase plasminogen activator receptor affects bone homeostasis by regulating osteoblast and osteoclast | 1-gen-2007 | Furlan F.; Galbiati C.; Jorgensen N.R.; Jensen JE.; Mrak E.; Rubinacci A.; Talotta F.; Verde P.; Blasi F. |